Skip to main content
Erschienen in: Journal of Endocrinological Investigation 10/2020

01.10.2020 | Original Article

Primary hyperparathyroidism and pancreatitis

verfasst von: R. A. Misgar, M. H. Bhat, T. A. Rather, S. R. Masoodi, A. I. Wani, M. I. Bashir, M. A. Wani, A. A. Malik

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The true association between primary hyperparathyroidism (PHPT) and pancreatitis continues to be controversial. In this study, we present clinical data, investigative profile, management and follow-up of PHPT patients with pancreatitis and compare this group with PHPT patients without pancreatitis.

Methods

Records of 242 patients with PHPT managed at our center over 24 years were retrospectively analyzed for demographic and laboratory data. The diagnosis of pancreatitis was entertained in the presence of at least two of the three following features: abdominal pain, levels of serum amylase greater than three times the normal or characteristic features at imaging.

Results

Fifteen (6.19%) of the 242 consecutive patients with PHPT had had pancreatitis. Fourteen patients (93.3%) had acute pancreatitis (AP), while one patient had chronic calcific pancreatitis. Over half (8 of 14) of the patients with AP had at least two episodes of pancreatitis. Pancreatitis was the presenting symptom in 14 (93.3%) patients. None of the pancreatitis cases had additional risk factors for pancreatitis. PHPT patients with pancreatitis had significantly higher serum calcium and ALP than PHPT patients without pancreatitis. After successful parathyroidectomy, 14 patients had no further attacks of pancreatitis during a median follow-up of 16 months (range 2–41 months), while recurrence of pancreatitis was seen in one patient.

Conclusions

We conclude that pancreatitis can be the only presenting complaint of PHPT. Our study highlights the importance of fully investigating for PHPT in any pancreatitis patient with high normal or raised serum calcium level, especially in the absence of other common causes of pancreatitis.
Literatur
1.
Zurück zum Zitat Ruda JM, Hollenbeak CS, Stack BC Jr (2005) A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132:359–372PubMedCrossRef Ruda JM, Hollenbeak CS, Stack BC Jr (2005) A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132:359–372PubMedCrossRef
2.
Zurück zum Zitat AACE/AAES Task Force on Primary Hyperparathyroidism (2005) The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 11:49–54CrossRef AACE/AAES Task Force on Primary Hyperparathyroidism (2005) The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 11:49–54CrossRef
3.
Zurück zum Zitat Misgar RA, Dar PM, Masoodi SR, Ahmad M, Wani KA, Wani AI, Bashir MI (2016) Clinical and laboratory profile of primary hyperparathyroidism in Kashmir Valley: a single-center experience. Indian J Endocr Metab 20:696–701CrossRef Misgar RA, Dar PM, Masoodi SR, Ahmad M, Wani KA, Wani AI, Bashir MI (2016) Clinical and laboratory profile of primary hyperparathyroidism in Kashmir Valley: a single-center experience. Indian J Endocr Metab 20:696–701CrossRef
4.
Zurück zum Zitat Misgar RA, Sehgal A, Masoodi SR, Wani AI, Bashir MI, Malik AA, Wani MA, Wani MM, Wani IA (2019) A comparison between silent and symptomatic renal stones in primary hyperparathyroidism. Indian J Endocr Metab 23:46–49CrossRef Misgar RA, Sehgal A, Masoodi SR, Wani AI, Bashir MI, Malik AA, Wani MA, Wani MM, Wani IA (2019) A comparison between silent and symptomatic renal stones in primary hyperparathyroidism. Indian J Endocr Metab 23:46–49CrossRef
5.
Zurück zum Zitat Misgar RA, Mathew V, Pandit K, Chowdhury S (2011) Primary hyperparathyroidism presenting as recurrent acute pancreatitis: a case report and review of literature. Indian J Endocr Metab 15:54–56CrossRef Misgar RA, Mathew V, Pandit K, Chowdhury S (2011) Primary hyperparathyroidism presenting as recurrent acute pancreatitis: a case report and review of literature. Indian J Endocr Metab 15:54–56CrossRef
6.
Zurück zum Zitat Smith FB, Cook RT (1940) Acute fatal hyperparathyroidism. Lancet 2:650CrossRef Smith FB, Cook RT (1940) Acute fatal hyperparathyroidism. Lancet 2:650CrossRef
7.
Zurück zum Zitat Jacob JJ, John M, Thomas N, Chacko A, Cherian R, Selvan B, Nair A, Seshadri M (2006) Does hyperparathyroidism cause pancreatitis? A south indian experience and a review of published work. Anz j surg 76:740–744PubMedCrossRef Jacob JJ, John M, Thomas N, Chacko A, Cherian R, Selvan B, Nair A, Seshadri M (2006) Does hyperparathyroidism cause pancreatitis? A south indian experience and a review of published work. Anz j surg 76:740–744PubMedCrossRef
8.
Zurück zum Zitat Agarwal A, George RK, Gupta SK, Mishra SK (2003) Pancreatitis in patients with primary hyperparathyroidism. Indian J Gastroenterol 22:224–225PubMed Agarwal A, George RK, Gupta SK, Mishra SK (2003) Pancreatitis in patients with primary hyperparathyroidism. Indian J Gastroenterol 22:224–225PubMed
9.
Zurück zum Zitat Carnaille B, Oudar C, Pattou F, Combemale F, Rocha J, Proye C (1998) Pancreatitis and primary hyperparathyroidism: forty cases. Aust N Z J Surg 68:117–119PubMedCrossRef Carnaille B, Oudar C, Pattou F, Combemale F, Rocha J, Proye C (1998) Pancreatitis and primary hyperparathyroidism: forty cases. Aust N Z J Surg 68:117–119PubMedCrossRef
10.
Zurück zum Zitat Koppelberg T, Bartsch D, Printz H, Hasse C, Rothmund M (1994) Pancreatitis in primary hyperparathyroidism (pHPT) is a complication of advancedpHPT. Dtsch Med Wochenschr 119:719–724PubMedCrossRef Koppelberg T, Bartsch D, Printz H, Hasse C, Rothmund M (1994) Pancreatitis in primary hyperparathyroidism (pHPT) is a complication of advancedpHPT. Dtsch Med Wochenschr 119:719–724PubMedCrossRef
11.
Zurück zum Zitat Bhadada SK, Udawat HP, Bhansali A, Rana SS, Sinha SK, Bhasin DK (2008) Chronic pancreatitis in primary hyperparathyroidism: comparison with alcoholic and idiopathic chronic pancreatitis. J Gastroenterol Hepatol 23:959–964PubMedCrossRef Bhadada SK, Udawat HP, Bhansali A, Rana SS, Sinha SK, Bhasin DK (2008) Chronic pancreatitis in primary hyperparathyroidism: comparison with alcoholic and idiopathic chronic pancreatitis. J Gastroenterol Hepatol 23:959–964PubMedCrossRef
12.
Zurück zum Zitat Bai HX, Geifer M, Patel M, Orabi AI, Husain SZ (2012) The association of primary hyperthyroidism with pancreatitis. J clinical Gastroenterol 46:656–661 Bai HX, Geifer M, Patel M, Orabi AI, Husain SZ (2012) The association of primary hyperthyroidism with pancreatitis. J clinical Gastroenterol 46:656–661
13.
Zurück zum Zitat Dubost C, Testart J, Choquart P, Kaswin R (1979) Les pancreatites de l'hyperparathyro'idie. Gastroenterol Clin Biol 3:621–630PubMed Dubost C, Testart J, Choquart P, Kaswin R (1979) Les pancreatites de l'hyperparathyro'idie. Gastroenterol Clin Biol 3:621–630PubMed
14.
Zurück zum Zitat Goebell H (1976) The role of calcium in pancreatic secretion and disease. Acta Hepato gastroenterol 23:151–161 Goebell H (1976) The role of calcium in pancreatic secretion and disease. Acta Hepato gastroenterol 23:151–161
15.
Zurück zum Zitat Bess MA, Edis AJ, van Heerden JA (1980) Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA 243:246–247PubMedCrossRef Bess MA, Edis AJ, van Heerden JA (1980) Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA 243:246–247PubMedCrossRef
16.
Zurück zum Zitat Khoo TK, Vege SS, Abu-Lebdeh HS, Ryu E, Nadeem S, Wermer RA (2009) Acute pancreatitis in primary hyperparathyroidism: a population-based study. J Clin Endocrinol Metab 94:2115–2118PubMedPubMedCentralCrossRef Khoo TK, Vege SS, Abu-Lebdeh HS, Ryu E, Nadeem S, Wermer RA (2009) Acute pancreatitis in primary hyperparathyroidism: a population-based study. J Clin Endocrinol Metab 94:2115–2118PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Sisman P, Avci M, Akkurt A, Sahin AB, Gul OO, Ersoy C, Erturk E (2018) The effect of primary hyperparathyroidism on pancreatic exocrine function. J Endocrinol Invest 41:293–298PubMedCrossRef Sisman P, Avci M, Akkurt A, Sahin AB, Gul OO, Ersoy C, Erturk E (2018) The effect of primary hyperparathyroidism on pancreatic exocrine function. J Endocrinol Invest 41:293–298PubMedCrossRef
18.
Zurück zum Zitat Prinz RA, Aranha GV (1985) The association of primary hyperparathyroidism and pancreatitis. Am Surg 51:325–329PubMed Prinz RA, Aranha GV (1985) The association of primary hyperparathyroidism and pancreatitis. Am Surg 51:325–329PubMed
19.
Zurück zum Zitat Shepherd JJ (1996) Hyperparathyroidism presenting as pancreatitis or complicated by postoperative pancreatitis. Aust N Z J Surg 66:85–87PubMedCrossRef Shepherd JJ (1996) Hyperparathyroidism presenting as pancreatitis or complicated by postoperative pancreatitis. Aust N Z J Surg 66:85–87PubMedCrossRef
20.
Zurück zum Zitat FelderbauerP KE, Fendrich V et al (2011) Multifactorial genesis of pancreatitis in primary hyperparathyroidism: evidence for “protective” (PRSS2) and “destructive” (CTRC) genetic factors. Exp Clin Endocrinol Diabetes 119:26–29CrossRef FelderbauerP KE, Fendrich V et al (2011) Multifactorial genesis of pancreatitis in primary hyperparathyroidism: evidence for “protective” (PRSS2) and “destructive” (CTRC) genetic factors. Exp Clin Endocrinol Diabetes 119:26–29CrossRef
21.
Zurück zum Zitat Bist SS, Ahuja V, Agrawal V, Modi S (2016) Recurrent acute pancreatitis: a diagnostic clue to primary hyperparathyroidism. Iran J Med Sci 41:361–362PubMed Bist SS, Ahuja V, Agrawal V, Modi S (2016) Recurrent acute pancreatitis: a diagnostic clue to primary hyperparathyroidism. Iran J Med Sci 41:361–362PubMed
22.
Zurück zum Zitat Chowdhury SD, Kurien RT, Pal S et al (2014) Acute pancreatitis and hyperparathyroidism: a case series. Indian J Gastroenterol 33:175–177PubMedCrossRef Chowdhury SD, Kurien RT, Pal S et al (2014) Acute pancreatitis and hyperparathyroidism: a case series. Indian J Gastroenterol 33:175–177PubMedCrossRef
23.
Zurück zum Zitat Haverback BJ, Dyce D, Bundy H (1960) Trypsin, trypsinogen, and trypsin inhibitor in human pancreatic juice: mechanism for pancreatitis associated with hyperparathyroidism. Am J Med 29:424–433CrossRef Haverback BJ, Dyce D, Bundy H (1960) Trypsin, trypsinogen, and trypsin inhibitor in human pancreatic juice: mechanism for pancreatitis associated with hyperparathyroidism. Am J Med 29:424–433CrossRef
25.
Zurück zum Zitat Felderbauer P, Karakas E, Fendrich V, Bulut K, Horn T, Lebert R, Holland- Letz T, Schmitz F, Bartsch D, Schmidt WE (2008) Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene. Am J Gastroenterol 103:368–374PubMedCrossRef Felderbauer P, Karakas E, Fendrich V, Bulut K, Horn T, Lebert R, Holland- Letz T, Schmitz F, Bartsch D, Schmidt WE (2008) Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene. Am J Gastroenterol 103:368–374PubMedCrossRef
26.
Zurück zum Zitat Sitges-Serra A, Alonso M, de Lecea C, Gores PF, Sutherland DE (1988) Pancreatitis and hyperparathyroidism. Br J Surg 75:158–160PubMedCrossRef Sitges-Serra A, Alonso M, de Lecea C, Gores PF, Sutherland DE (1988) Pancreatitis and hyperparathyroidism. Br J Surg 75:158–160PubMedCrossRef
Metadaten
Titel
Primary hyperparathyroidism and pancreatitis
verfasst von
R. A. Misgar
M. H. Bhat
T. A. Rather
S. R. Masoodi
A. I. Wani
M. I. Bashir
M. A. Wani
A. A. Malik
Publikationsdatum
01.10.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 10/2020
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-020-01233-5

Weitere Artikel der Ausgabe 10/2020

Journal of Endocrinological Investigation 10/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.